ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD)

Profile

Full Name

ACADIA Pharmaceuticals Inc.

Ticker

NASDAQ: ACAD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 27, 2004

Indexes

Not included

Website

https://www.acadia.com

Employees

653

Key Details

Price

$23.53(-1.26%)

Market cap

$3.94B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$957.80M(+31.85% YoY)

Annual EPS

$1.36(+467.57% YoY)

PE ratio

17.18

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $23.53
    ACAD price is $23.53

    30-Day Relative Volume

    0.92
    ACAD 30-day relative volume is 0.92

    Price Performance

    Price Most recent change

    -1.26%
    ACAD price was down -1.26% on Aug 1, 2025

    Price YTD change

    +28.23%
    ACAD price is up +28.23% since January 1st

    Price 1-year change

    +25.36%
    ACAD price is up +25.36% year-on-year

    Price 3-year change

    +50.64%
    ACAD price is up +50.64% over the past 3 years

    Price Range

    Price All-time high

    $58.72
    ACAD price is currently -59.93% below its historical high of $58.72

    Price 3-year low

    $13.40
    ACAD price is currently +75.60% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.94B
    ACAD market capitalization is $3.94 billion

    Market cap 3-year change

    +55.78%
    ACAD market capitalization is up +55.78% over the past 3 years

    Market cap All-time high

    $9.03B
    ACAD market capitalization is currently -56.38% below its historical high of $9.03 billion

    Market cap sector rank

    87.37%
    ACAD market capitalization is higher than 87.37% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.9%
    ACAD shares outstanding is up +0.9% year-on-year

    Shares Outstanding 3-Year Change

    +3.41%
    ACAD shares outstanding is up +3.41% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.90
    ACAD beta is 0.90

    200-day SMA

    $18.27
    ACAD price is currently +28.79% above its 200-day simple moving average

    50-day SMA

    $22.17
    ACAD price is currently +6.15% above its 50-day simple moving average

    RSI

    61.47
    ACAD 14-day relative strength index is 61.47

    Volume

    0.92
    ACAD 30-day relative volume is 0.92

    ATR

    $0.75
    ACAD average true range is $0.75

    10-day Historical Volatility

    33.02%
    ACAD 10-day historical volatility is 33.02%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $957.80M
    ACAD annual revenue is $957.80 million

    Revenue Analysts estimate

    $1.06B
    ACAD annual revenue is currently -9.95% lower than the consensus analysts' forecast

    Revenue 1-year change

    +31.85%
    ACAD annual revenue is up +31.85% year-on-year

    Revenue Sector rank

    79.86%
    ACAD annual revenue is higher than 79.86% of companies in Healthcare sector

    EPS

    EPS

    $1.36
    ACAD annual earnings per share is $1.36

    EPS Analysts estimate

    $0.51
    ACAD annual earnings per share is currently +167.40% higher than the consensus analysts' forecast

    EPS 1-year change

    +467.57%
    ACAD annual earnings per share is up +467.57% year-on-year

    EPS Sector rank

    90.44%
    ACAD annual earnings per share is higher than 90.44% of companies in Healthcare sector

    Profit

    Gross profit

    $875.96M
    ACAD annual gross profit is $875.96 million

    Gross margin

    91.46%
    ACAD annual gross profit margin is 91.46%

    Operating profit

    $84.28M
    ACAD annual operating income is $84.28 million

    Operating margin

    8.80%
    ACAD annual operating profit margin is 8.80%

    Net income

    $226.45M
    ACAD annual net profit is $226.45 million

    Net margin

    23.64%
    ACAD annual net profit margin is 23.64%

    Expenses

    Total expenses

    $873.52M
    ACAD annual total expenses is $873.52 million

    Operating expenses

    $791.68M
    ACAD annual total operating expenses is $791.68 million

    Cost of goods sold

    $81.84M
    ACAD annual cost of goods sold is $81.84 million

    Selling, general & administrative expenses

    $488.43M
    ACAD annual SGA is $488.43 million

    Depreciation and amortization

    $15.88M
    ACAD annual depreciation & amortization is $15.88 million

    Interest expense

    -
    ACAD annual interest expense value is unknown

    Income tax

    $31.62M
    ACAD annual income tax is $31.62 million

    EBIT & EBITDA

    EBIT

    $84.28M
    ACAD annual earnings before interest & taxes is $84.28 million

    EBITDA

    $100.16M
    ACAD annual EBITDA is $100.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.19B
    ACAD annual total assets is $1.19 billion

    Non current assets

    $249.44M
    ACAD annual long term assets is $249.44 million

    Current assets

    $938.32M
    ACAD annual total current assets is $938.32 million

    Cash and cash equivalents

    $319.59M
    ACAD annual cash & cash equivalents is $319.59 million

    Accounts receivable

    $98.74M
    ACAD annual accounts receivable is $98.74 million

    Inventory

    $21.95M
    ACAD annual inventory is $21.95 million

    Liabilities

    Total liabilities

    $454.96M
    ACAD annual total liabilities is $454.96 million

    Long term liabilities

    $60.09M
    ACAD annual total long term liabilities is $60.09 million

    Current liabilities

    $394.87M
    ACAD annual total current liabilities is $394.87 million

    Accounts payable

    $16.19M
    ACAD annual accounts payable is $16.19 million

    Debt

    Total debt

    $51.99M
    ACAD annual total debt is $51.99 million

    Total debt 1-year change

    -9.11%
    ACAD annual total debt is down -9.11% year-on-year

    Long term debt

    $42.04M
    ACAD annual long term debt is $42.04 million

    Short term debt

    $9.96M
    ACAD annual short term debt is $9.96 million

    Equity & Capital

    Shareholders equity

    $732.79M
    ACAD annual stockholders equity is $732.79 million

    Book value

    $732.79M
    ACAD annual book value is $732.79 million

    Retained earnings

    -$2.20B
    ACAD annual retained earnings is -$2.20 billion

    Working capital

    $543.45M
    ACAD annual working capital is $543.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $157.72M
    ACAD annual cash flow from operations is $157.72 million

    Cash from operations 1-year change

    +844.31%
    ACAD annual cash flow from operations is up +844.31% year-on-year

    Cash from investing

    -$30.54M
    ACAD annual cash flow from investing activities is -$30.54 million

    Cash from investing 1-year change

    -195.44%
    ACAD annual cash flow from investing activities is down -195.44% year-on-year

    Cash from financing

    $6.84M
    ACAD annual cash flow from financing activities is $6.84 million

    Cash from financing 1-year change

    -72.76%
    ACAD annual cash flow from financing activities is down -72.76% year-on-year

    CAPEX

    CAPEX

    $523.00K
    ACAD annual capital expenditures is $523.00 thousand

    CAPEX 1-year change

    -98.69%
    ACAD annual capital expenditures is down -98.69% year-on-year

    Free Cash Flow

    Free cash flow

    $157.20M
    ACAD annual free cash flow is $157.20 million

    Free cash flow 1-year change

    +773.27%
    ACAD annual free cash flow is up +773.27% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.46%
    ACAD annual gross profit margin is 91.46%

    Operating margin

    8.80%
    ACAD annual operating profit margin is 8.80%

    Net margin

    23.64%
    ACAD annual net profit margin is 23.64%

    ROA & ROE

    ROA

    23.39%
    ACAD annual return on assets is 23.39%

    ROE

    38.89%
    ACAD annual return on equity is 38.89%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    17.18
    ACAD price to earnings ratio is 17.18

    PE ratio Sector rank

    36.62%
    ACAD price to earnings ratio is higher than 36.62% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.15
    ACAD price to book ratio is 5.15

    PB ratio Sector rank

    80.75%
    ACAD price to book ratio is higher than 80.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.95
    ACAD price to sales ratio is 3.95

    PS ratio Sector rank

    57.33%
    ACAD price to sales ratio is higher than 57.33% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.78B
    ACAD enterprise value is $3.78 billion

    Enterprise value Sector rank

    86.04%
    ACAD enterprise value is higher than 86.04% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    37.14
    ACAD EV/EBITDA is 37.14

    EV/EBITDA Sector rank

    95.4%
    ACAD EV/EBITDA is higher than 95.4% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.38
    ACAD annual current ratio is 2.38

    Quick ratio

    2.32
    ACAD annual quick ratio is 2.32

    Leverage

    Debt to equity

    0.00
    ACAD annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ACAD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    ACAD piotroski f-score is 6

    Altman Z-Score

    4.18
    ACAD altman z-score is 4.18

    Analyst ratings

    Recent major analysts updates

    Jul 24, 25 JP Morgan
    Overweight
    Jun 26, 25 Oppenheimer
    Perform
    Jun 26, 25 Needham
    Buy
    Jun 26, 25 JMP Securities
    Market Outperform
    Jun 26, 25 HC Wainwright & Co.
    Buy
    Jun 23, 25 RBC Capital
    Outperform
    Jun 6, 25 JP Morgan
    Overweight
    Jun 5, 25 B of A Securities
    Neutral
    May 21, 25 Deutsche Bank
    Buy
    May 20, 25 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with ACAD included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for ACADIA Pharmaceuticals Inc.?
    • Does ACADIA Pharmaceuticals Inc. pay dividends?
    • What sector is ACADIA Pharmaceuticals Inc. in?
    • What industry is ACADIA Pharmaceuticals Inc. in?
    • What country is ACADIA Pharmaceuticals Inc. based in?
    • When did ACADIA Pharmaceuticals Inc. go public?
    • Is ACADIA Pharmaceuticals Inc. in the S&P 500?
    • Is ACADIA Pharmaceuticals Inc. in the NASDAQ 100?
    • Is ACADIA Pharmaceuticals Inc. in the Dow Jones?
    • When was ACADIA Pharmaceuticals Inc.'s last earnings report?
    • When does ACADIA Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for ACADIA Pharmaceuticals Inc.?

    The ticker symbol for ACADIA Pharmaceuticals Inc. is NASDAQ:ACAD

    Does ACADIA Pharmaceuticals Inc. pay dividends?

    No, ACADIA Pharmaceuticals Inc. does not pay dividends

    What sector is ACADIA Pharmaceuticals Inc. in?

    ACADIA Pharmaceuticals Inc. is in the Healthcare sector

    What industry is ACADIA Pharmaceuticals Inc. in?

    ACADIA Pharmaceuticals Inc. is in the Biotechnology industry

    What country is ACADIA Pharmaceuticals Inc. based in?

    ACADIA Pharmaceuticals Inc. is headquartered in United States

    When did ACADIA Pharmaceuticals Inc. go public?

    ACADIA Pharmaceuticals Inc.'s initial public offering (IPO) was on May 27, 2004

    Is ACADIA Pharmaceuticals Inc. in the S&P 500?

    No, ACADIA Pharmaceuticals Inc. is not included in the S&P 500 index

    Is ACADIA Pharmaceuticals Inc. in the NASDAQ 100?

    No, ACADIA Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is ACADIA Pharmaceuticals Inc. in the Dow Jones?

    No, ACADIA Pharmaceuticals Inc. is not included in the Dow Jones index

    When was ACADIA Pharmaceuticals Inc.'s last earnings report?

    ACADIA Pharmaceuticals Inc.'s most recent earnings report was on May 8, 2025

    When does ACADIA Pharmaceuticals Inc. report earnings?

    The next expected earnings date for ACADIA Pharmaceuticals Inc. is August 6, 2025
    On this page